190792-74-6Relevant articles and documents
N -phosphonocarbonylpyrrolidine derivatives of guanine: A new class of Bi-substrate inhibitors of human purine nucleoside phosphorylase
Rejman, Dominik,Panova, Natalya,Klener, Pavel,Maswabi, Bokang,Pohl, Radek,Rosenberg, Ivan
, p. 1612 - 1621 (2012/05/05)
A complete series of pyrrolidine nucleotides, (3R)- and (3S)-3-(guanin-9-yl)pyrrolidin-1-N-ylcarbonylphosphonic acids and (3S,4R)-, (3R,4S)-, (3S,4S)-, and (3R,4R)-4-(guanin-9-yl)-3-hydroxypyrrolidin-1-N- ylcarbonylphosphonic acids, were synthesized and e
THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS
-
Page/Page column 40, (2010/01/12)
A series of thieno[2,3-6]pyridine derivatives, attached at the 2-position to a substituted anilino moiety, which are substituted in the 3-position by a carbonyl group linked to a pyrrolidin-1-yl ring which in turn forms part of a heteroatom-containing fus
MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE
-
Page/Page column 25, (2009/07/10)
The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.